Rita Ambrus

New aspects of developing a dry powder inhalation formulation applying the quality-by-design approach.

Edina Pallagi, Keyhaneh Karimi, Rita Ambrus, 2016, International journal of pharmaceutics.

Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation.

Edina Pallagi, Rita Ambrus, Piroska Szabó-Révész, 2015, International journal of pharmaceutics.

Development of oral lyophilisates containing meloxicam nanocrystals using QbD approach

Rita Ambrus, Piroska Szabó-Révész, Sonia Iurian, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Optimization of a combined wet milling process in order to produce poly(vinyl alcohol) stabilized nanosuspension

Rita Ambrus, Piroska Szabó-Révész, Orsolya Jójárt-Laczkovich, 2018, Drug design, development and therapy.

In vitro and in vivo characterization of meloxicam nanoparticles designed for nasal administration.

Rita Ambrus, Piroska Szabó-Révész, Szilvia Veszelka, 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Study of the parameters influencing the co-grinding process for the production of meloxicam nanoparticles

Rita Ambrus, Piroska Szabó-Révész, Ákos Kukovecz, 2011 .

Design and characterization of loratadine nanosuspension prepared by ultrasonic‐assisted precipitation

Rita Ambrus, Ildikó Csóka, R. Ambrus, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Analysis of niflumic acid prepared by rapid microwave-assisted evaporation.

Norbert Radacsi, Rita Ambrus, Piroska Szabó-Révész, 2014, Journal of pharmaceutical and biomedical analysis.